Number Needed to Treat: Analyzing of the Effectiveness of Thoracoabdominal Aortic Repair  by Miller, C.C et al.
Number Needed to Treat: Analyzing of the Effectiveness of
Thoracoabdominal Aortic Repair
C. C. Miller III*, E. E. Porat, A. L. Estrera, A. N. Vinnerkvist, T. T. T. Huynh and H. J. Safi
The Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center at
Houston, Medical School, Houston, USA
Background. Number needed to treat (NNT) is a method used to calculate the number of patients who need to be treated to
prevent one adverse outcome. To analyze the effectiveness of thoracoabdominal and descending thoracic aortic aneurysm
repair, we computed the NNT required to prevent one death.
Methods. Between Jan 1991 and Feb 2003, we repaired 1004 aneurysms of the descending thoracic and thoracoabdominal
aorta. We followed the patients from surgery until death. Five-year actuarial survival in our population was computed by the
Kaplan–Meier method. Natural history data for comparison were taken from the population-based work of Bickerstaff et al.,
1982. NNT was calculated as the reciprocal of the risk difference at 5 years. 95% confidence intervals were computed by the
method of Daly.
Results. Five-year mortality in the population-based cohort was 87 vs. 39% in our treated population, for a risk difference of
48%. 1/0.48 ¼ 2, indicating that two patients need to be treated to prevent one death at 5 years (95% CI 1.8–2.5,
p , 0.0001).
Conclusion. An NNT of two demonstrates the effectiveness of surgical repair of descending thoracic and thoracoabdominal
aortic aneurysms when compared to the natural history. By comparison, carotid endarterectomy for symptomatic lesions
.70% has an NNTof 15 to prevent a single stroke or death. NNTcan also be applied to aneurysm size criteria to estimate the
effort required to prevent death or rupture for a given aneurysm size.
Key Words: Number needed to treat; Thoracoabdominal aortic aneurysm; Descending; Thoracic aortic aneurysm; Aortic
aneurysm.
Introduction
The practice of surgery is a highly individual process.
Treatment plans are made case-by-case and no two
cases are ever identical. For this reason, surgeons may
focus on the individual patient more than the
population from which the individual arises; yet
many interesting questions exist about the effects of
surgical techniques on the population itself. One such
question is that of how much clinical effort is required
to produce a single good outcome (or to prevent a bad
one) in a population of patients. We may know the
probability that a patient will be well following an
operation, but how much the procedure actually
benefits the population depends on how the patient
would have done without it. Number needed to treat
(NNT) is a function of the probability of a treatment
success versus the probability of a success without
treatment. It is a statistical method that measures the
numberof times a treatmenthas tobeapplied toproduce
one desired result. Thoracoabdominal aortic aneurysm
repair is an expensive and highly invasive procedure, so
some sense of how frequently it is successful compared
to the alternative of no treatment is of interest.
Methods
Between January 1991 and February 2003, we repaired
thoracoabdominal (TAAA) or descending thoracic
aortic aneurysms in 1004 patients. Three hundred
seventy-three patients (37.2%) were female, 631
(62.8%) were male. Median age was 67 (range 8–88);
205 (20.4%) had extensive type II aneurysms. Forty-
one patients (4.1%) had operation for acute type B
aortic dissection. Eighty-nine (8.9%) had preoperative
renal insufficiency.
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Surgical methods
Our usual technique is described in detail elsewhere.1,2
Briefly, it is as follows. Anesthesia is induced and a
catheter is placed in the 3rd or 4th lumbar space to
regulate and measure cerebrospinal fluid pressure.
Pressure is maintained at less than 10 mmHg through-
out the procedure and for 72 h post-operatively.
Depending on extent of the aneurysm, a left thor-
acoabdominal incision is made. The diaphragm is
exposed and the aortic hiatus is retracted, but the
central tendon and the muscular portion of the
diaphragm are not divided. The patient is antic-
oagulated with heparin, and the left atrium is
cannulated via the left pulmonary vein or the left
atrial appendage. A BioMedicus (Minneapolis, MN)
pumpwith an in-line heat exchanger is attached to this
cannula and the arterial inflow is established through
the left common femoral artery, or the descending
thoracic aorta, if the femoral artery is not accessible.
For extensive aneurysms, sequential clamping is used.
When technically feasible, patent lower thoracic
intercostals arteries (T8–T12) are reattached to the
aortic graft. When they are exposed, the celiac,
superior mesenteric, and renal arteries are perfused
with cold perfusate (blood at 4 8C). Renal temperature
is maintained at approximately 15 8C, but core body
temperature is kept between 32 and 33 8C to avoid
hypothermia.
Statistical methods
This study uses an ambidirectional cohort design, with
a retrospective population-based study serving as the
unexposed cohort and our surgical series serving as
the exposed cohort (exposure being membership in
surgical population). Data for the surgical cohort were
collected prospectively in our patient population on
standardized data forms from the history and physical
exam, in the operating room during surgery, and in the
intensive care unit after surgery. Charts were reviewed
after discharge to capture any adverse events that
occurred out on the floor between discharge from the
ICU and discharge from the hospital. We followed
patients after surgery several ways; (1) by sending out
periodic follow-up surveys, (2) by maintaining all
correspondence from patients, families and referring
physicians, (3) by searching the U.S. Social Security
Death Databases for all U.S. residents who have social
security numbers. Five-year survival was estimated by
Kaplan–Meier method using SAS software version
8.2.
The unexposed population was that described by
Bickerstaff and colleagues in 1982.3 This was a
population-based epidemiological study of thoracic
aneurysm incidence and survival conducted in Olm-
stead County Minnesota using data from the Roche-
ster Epidemiology Project, over a 30-year period.
Briefly, this study reviewed medical records of all
patients with a diagnosis of thoracic aortic aneurysm
in the county. Diagnosis was confirmed by autopsy,
operation or roentgenography, and long-term survival
was computed frommedical record data. Survival was
computed using actuarial methods.
The risk difference was calculated as the absolute
reduction in risk attributed to TAAA repair. It is the 5
year probability of survival in the treated groupminus
the same statistic in the control population. The 95%
confidence interval for the risk difference was com-
puted by the method of Daly.4 NNTwas computed as
the reciprocal of the risk difference, and the 95%
confidence interval was the inverted risk difference
confidence interval.5
Results
Five-year actuarial mortality in our cohort was 39%
(61% survival) (Fig. 1). This is as compared to 87%
(13% survival) in the untreated population cohort. The
risk difference is 0.61 2 0.13 ¼ 0.48. 1/0.48 ¼ 2.08, or
approximately one death prevented at five years for
every two patients treated. 95% CI is 1.8–2.5, p ,
0:0001:
Discussion
Thoracoabdominal aortic aneurysm repair is highly
effective compared to the experience of the popu-
lation-based cohort, 89% of which had untreated aortic
disease. In this study, NNT is equal to 2, p , 0:0001:
Fig. 1. Actuarial survival in our TAAA repair population
compared to the population-based control described by
Bickerstaff et al., 1982. The risk difference is shown.
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NNT is a transformation of the risk difference, which
for two groups is the difference between the risk of an
adverse outcome in an untreated group and the risk of
the same outcome in a treated group. In a case where
the disease outcome were uniformly bad and the
treatment were uniformly curative, NNT would be
equal to one; one patient treated equals a single cure.
Low NNT means that less clinical effort is required to
produce a favorable result in a target population.
Table 1 shows numbers needed to treat for several
widely used treatments. Compared to these treat-
ments, many of which are considered to be highly
efficacious, thoracoabdominal aortic repair has a very
low NNT. But this is not to say that treatments with
large NNTs are not worthwhile. Whether or not a
treatment is worthwhile depends on its expense, side
effects, acceptability, and how important it is to
produce the outcome. Although clinicians tend to
like the descriptiveness of the NNT, statisticians are
generally less impressed.15 The two major objections
raised by statisticians are that the distributional
properties of the NNT are poorly understood,16 and
that the confidence interval splits into two parts when
the NNT is not significant.15 When a statistical
measure is not significant at the p , 0:05 level, its
95% confidence interval spans the null value, indicat-
ing that the effect being tested cannot be said to be
significantly different from the null value. As the NNT
is a reciprocal transformation of the risk difference, so
is the 95% confidence interval for NNT a reciprocal
transformation of the 95% confidence interval for the
risk difference. The null value of the risk difference is
zero (no difference between groups), and a non-
significant confidence interval might extend below
zero. The reciprocal of zero is infinity (division by
zero), and this is what splits the confidence interval for
the NNT when the confidence interval for the risk
difference spans zero. Fig. 2 demonstrates this pro-
blem. In the hypothetical example, a non-significant
NNT of 10 has a 95% confidence interval that is
bounded by infinity on the upper end and minus
infinity on the lower. The point estimate is 10, the
positive bound is about 4, and the negative bound is
about 220. A negative NNT is thought of as the
number needed to harm, so that an NNTof220 would
mean that for every 20 patients treated one is worse off
than he or she would have been had the treatment
been withheld. The concept of a number needed to
harm allows the confidence interval to be reformu-
lated in a continuous manner as in Fig. 3. Here, the
lower bound of a non-significant NNT protrudes into
the territory of number needed to harm. So the
uncertainty associated with the point estimate is
such that the treatment could be as effective as an
NNT of 4 (upper bound), or as poor as a NNH of 20
(lower bound). This formulation makes a sensible
confidence interval.
Ideally, NNT is interpreted in the context of a
randomized clinical trial, where the true attributable
risk of a treatment (or in this case no treatment) can be
assessed. In the case of life threatening thoracic and
thoracoabdominal aortic aneurysms, randomization to
no treatment would be unacceptable for ethical
reasons. Therefore, a true contemporaneous control
will likely never exist for thoracoabdominal aortic
repair. Still, the question is of significant clinical
interest, and any study of the effectiveness of the
procedure must be done with the best resources
available. The study of Bickerstaff and colleagues is a
classic in the literature and remains the definitive
population-based long-term study. A large proportion
of the cases reported in Bickerstaff’s population (62%)
Table 1. NNTs, for some common treatments
Treatment NNT To prevent Ref.
TAAA repair 2 1 Death/5 yr
Antibiotic Px for dog bites 4 1 Wound infection 6
Hep. B vaccine in HCWs 7 1 Infection in 200/1000/year baseline 7
CEA—severe stenosis 15 1 Stroke or death/5 yr 8
Triple antibiotics for H. Pylori 15 1 Case of dyspepsia 9
10 d antibiotics for otitis media 17 1 Treatment failure vs. 5 d course 10
CEA—moderate stenosis 21 1 Stroke or death/5 yr 8
Fluoride gel in children 24 1 Cavity/yr with a baseline of 0.2/yr 11
LMW heparin after total hip 64 1 Sx venous thromboembolism 12
Hep. B vaccine in HCWs 145 1 Infection in 10/1000/year baseline 7
Aspirin for cardiac Px 153 1 Cardiac event/yr; 5% baseline 13
LMW heparin after total hip 278 1 Sx pulmonary thromboembolism 12
Aspirin for cardiac Px 385 1 Cardiac event/yr; 2% baseline 13
AAA screening 1000* 1 Death/yr 14
TAAA, thoracoabdominal aortic aneurysm; Px, prophylaxis; Hep, hepatitis; HCW, healthcare worker; CEA, carotid endarterectomy; LMW,
low molecular weight; AAA, abdominal aortic aneurysm.
* þ 5 Operations among the 1000 AAA screened.
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have ascending aortic or aortic arch involvement, and
this does limit the accuracy of the match somewhat. It
is also true that Bickerstaff is not a completely non-
surgical population; 11% of the patients had surgical
repairs. But surgery in this cohort would be expected
to improve survival, and thus to bias the estimated
difference toward the null value. Similarly, since our
surgical cohort is a referral population, it contains
many complex cases that could not be managed in the
community, so this element of increased risk in our
surgical population should bias the estimated differ-
ence from the population-based sample downward.
At least some of the potential biases present should
force the groups to appear closer together than they
are, making apparent differences smaller than they
would otherwise be. This may be partially offset by
improvements in medical therapy in recent times. So
while the Bickerstaff population is by no means an
ideal unexposed cohort, it is the best comparison
group we are likely ever to have.
NNT is a convenient method for expressing the
impact of a treatment on the population in which it is
applied. In the population of patients with thoracoab-
dominal aortic aneurysms, surgical repair is highly
effective for preventing five-year mortality. The pro-
blems with the measure’s statistical properties are
minor and easily managed.
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Fig. 2. Non-significant 95% confidence interval with NNT
bounds disjoined by infinity. After Altman.5
Fig. 3. Altman’s solution: 95% confidence interval spans
infinity but ranges from NNT to number needed to harm
(NNH). Note that the order of the values is different in this
figure. NNT/NNH are largest near the infinity split mid-
figure and smaller on the periphery. The point estimate and
confidence interval for the highly significant effect of
thoracoabdominal aortic repair is shown at upper left.
After Altman.5
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